메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
저널정보
한국임상약학회 한국임상약학회지 한국임상약학회지 제23권 제4호
발행연도
2013.1
수록면
344 - 364 (21page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Background: Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are immune-complex-mediatedhypersensitivity reactions that predominantly involve skin and mucous membranes. Despite the low incidence, both areconsidered medical emergencies as the mortality rate has been estimated at 30-50%. Although as many as half of casesare idiopathic, several drugs have been implicated as main cause of SJS/TEN. This review therefore aimed to identifydrugs that were potentially associated with SJS/TEN and compare the relative risk of the medications. Method: A comprehensivesearch was performed using MEDLINE, EMBASE and 5 Korean databases. We defined study drugs as nonsteroidalanti-inflammatory drugs (NSAIDs), antibiotics, antiepileptics, and allopurinol. Only epidemiologic studiesinvestigating associations between the above drugs and drug-induced SJS/TEN were included. Two reviewers independentlyselected and evaluated candidate papers and extracted odds ratios or incidence rates. Meta-analysis was performedonly for drugs that were reported from 4 or more studies. Results: We found 8 case-control studies, 3 cohortstudies and 1 RCT. The ranges of adjusted ORs were 0.6-34.0 for NSAIDs, 1.6-302.0 for antiepileptics, 0.3-10.0 forantibiotics and 1.0-187.0 for allopurinol. The drug with the highest incidence of SJS/TEN was carbamazepine (40 persons/1,000 DDD). Conclusion: Finally, the risk was highest in first 8 weeks after onset of treatment in all drugs.

목차

등록된 정보가 없습니다.

참고문헌 (25)

참고문헌 신청

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0